Braskem Balanced Scorecard
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Dive Deeper Into the Growth Paths Behind the Analysis
This Braskem Balanced Scorecard Analysis gives you a clear, company-specific view of Braskem's financial, customer, internal process, and learning and growth priorities. The page already shows a real preview of the actual report content, so you can review the format and substance before buying. Purchase the full version to get the complete ready-to-use analysis.
Benefits
Bio-Based Feedstock Growth
Braskem's Balanced Scorecard can link "I'm green" polyethylene to hard targets, with its Brazilian sugarcane-based plant built for 200,000 tons a year. Tracking biopolymer revenue share turns the shift from fossil feedstock into a measurable 2025 financial signal, not just a brand story. That makes the circular-economy move easier for investors to price against carbon-neutrality goals.
Global Asset Synergy Tracking
Braskem's Global Asset Synergy Tracking links internal process metrics across 4 manufacturing bases in Brazil, Mexico, Germany, and the United States, so leaders can compare plant uptime on one scorecard.
It flags polyolefin units running above the 90% uptime mark and points maintenance CAPEX to the sites with the biggest EBITDA lift.
That makes local wins easier to copy across the network and helps protect consolidated EBITDA.
Strategic Working Capital Optimization
Strategic working capital optimization helps Braskem tighten inventory turns across naphtha, ethane, and propane flows, so cash is not trapped in feedstock. In 2025, that mattered more as polymer prices and freight stayed volatile, and every day shaved from the cash conversion cycle improved liquidity. The result is a bigger cash cushion and less stress when margins swing.
Circular Economy Innovation Velocity
Braskem's Circular Economy Innovation Velocity KPI shows how fast it turns recycling R&D into market-ready mechanical and chemical resin grades. In 2025, many global consumer brands still targeted about 30% recycled content in packaging, so faster patenting and resin launches can win supply contracts sooner. Tracking annual patents and new formulations also helps Braskem cut scale-up risk and keep premium circular products moving to customers.
Remediation Accountability Monitoring
Remediation accountability monitoring makes Braskem's internal process targets visible, so the executive team can track compensation and environmental repair tied to the Maceió geological crisis in real time. The case still affects about 60,000 properties, so clear milestone tracking matters for both speed and control. That transparency helps institutional investors judge whether remediation cash outlays are moving toward risk reduction, not just reserve use.
It also rebuilds trust by showing concrete progress on social and environmental recovery, not vague promises.
Braskem's 2025 KPIs turn sustainability and cash control into measurable gains
Braskem's balanced scorecard benefits come from turning sustainability, operations, and cash goals into measurable 2025 KPIs. Its 200,000-ton-a-year sugarcane plant makes biopolymer revenue and carbon cuts trackable, while plant uptime and working-capital metrics protect EBITDA and liquidity. Remediation tracking also gives investors a clearer view of Maceió-related execution risk.
| Benefit | 2025 signal |
|---|---|
| Green growth | 200,000 tons/year |
| Asset efficiency | 4 manufacturing bases |
| Liquidity | Inventory and cash-cycle control |
| Risk control | 60,000 properties |
What is included in the product
Detailed Word Document
Editable Excel File
Drawbacks
Commodity Cycle Distortion
Commodity Cycle Distortion is a real drawback for Braskem because scorecard financials often lag naphtha and polymer swings. In 2025, oil and petrochemical spreads stayed volatile, so fixed internal targets could make old margins look like current truth. That can push decisions toward yesterday's profit pool instead of the next quarter's feedstock outlook.
Legacy Liability Financial Drag
Braskem's scorecard is still distorted by Maceió, where multi-year provisions reached about R$15 billion by 2025 and keep pressuring consolidated profit and leverage. That drag can hide the stronger cash and cost profile of newer assets in Mexico and the US, which are far more efficient than legacy Brazilian sites. For analysts, this makes it hard to separate current management execution from structural liabilities tied to past geological damage.
Complex ESG Regulatory Compliance
Braskem's ESG scorecard gets messy fast: one standard must fit four jurisdictions, each with different disclosure rules. That means teams have to reconcile U.S. SEC climate demands with Latin American ESG frameworks, raising admin costs and slowing reporting cycles. The extra data-entry load pulls plant managers away from throughput, which matters when a large plant can process hundreds of thousands of tons a year.
R&D Spending Measurement Lags
R&D spending lags are a real weakness for Braskem because chemical recycling plants can need hundreds of millions of dollars upfront, while cash payoffs often do not show up for 5 to 10 years. If the balanced scorecard leans too hard on quarterly ROI, it can punish the kind of high-risk R&D needed to reach net-zero by 2050. That creates a sharp gap between near-term earnings pressure and the long-term need to stay viable in a lower-carbon market.
Standardization versus Regional Flexibility
Applying one KPI set across Braskem's 2025 footprint ignores local labor rules and infrastructure gaps. Brazil, the U.S., and Mexico face different port, rail, and wage conditions, so the same process targets can punish teams for issues outside their control. That rigidity can blur real performance and push managers to follow corporate reporting instead of adapting to local supply chain risk.
Braskem's 2025 scorecard is clouded by noise, debt, and global mismatch
Braskem's balanced scorecard still has three big drawbacks in 2025: commodity swings distort margin targets, Maceió provisions near R$15 billion keep leverage and profit signals noisy, and one KPI set does not fit Brazil, the US, and Mexico.
That makes near-term scorecards less useful for judging execution, especially when recycling R&D needs multi-year capital and payback.
| Drawback | 2025 data point |
|---|---|
| Maceió drag | ~R$15 billion provisions |
| Commodity noise | Volatile 2025 spreads |
| Global KPI mismatch | 3-country footprint |
What You See Is What You Get
Braskem Reference Sources
This is the actual Braskem Balanced Scorecard analysis document you'll receive after purchase-no samples, no surprises. The preview below is taken directly from the full report, so what you see is what you get. Once purchased, the complete version is unlocked for immediate use.
Frequently Asked Questions
Braskem integrates carbon-neutral targets into its internal process and learning perspectives to drive its 'I'm green' initiatives. For 2026, the company monitors the expansion of its biopolymer production toward a 1.0 million ton annual capacity goal. These metrics allow management to link green resin sales directly to long-term profitability and global carbon reduction incentives.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.